close

 

簡單詮釋身體幹細胞的作用 

 

你知道受傷時怎麼身體怎麼自我修復嗎?

我們身體有60兆的細胞, 骨髓裡有1.5億幹細胞,平常時大約5%在血液裡流動工作,身體組織受傷發出訊號時,幹細胞便會去修復它。 

所以幹細胞具有兩個特性: 1. 自己可複製自己  2. 可分化成不同的組織細胞(舉例: 胚胎)

身體最常發出受傷訊號的器官為: 心臟、腎臟、肝臟、骨骼肌、腦這些活躍的器官。

緊急時,受傷的組織會釋放出一種物質(G-CSF),會促使骨髓釋放幹細胞,

幹細胞受到呼喚,會去尋找受損的組織,進而進行附著(CXCR4),變成細胞來修復組織。年輕時血液裡幹細胞多,受傷了身體修復的快,

 組織釋放物質(SDF-1)呼喚幹細胞讓幹細胞可以迅速找到受損組織並附著( 幹細胞表皮接收器CXCR4與 SDF-1結合),就像插頭插到插座,立即進行複製, 變成該組織的細胞,

所以,手受傷不會長出眼睛,哈哈。

隨著年紀越來越大, 細胞死亡,工作的幹細胞也越來越少。

以下是介紹幹細胞的影片:

 

醫學期刊.jpg

一般人的誤解: 吃的幹細胞。

幹細胞無法用吃的, 吃的人會感覺有效是因為吃進一些從胎盤或其他物質取出的微量元素。

 

台灣衛福部開放自體幹細胞療法

主要開放項目:

第一至第三期實 體癌,經標準治 療無效:第一至 二級低度膠質細 胞瘤和第三級高 度惡性 膠質 瘤、上皮性卵巢 癌、胰臟癌、攝 護腺癌、頭頸 癌、肝癌、乳 癌、大腸直腸癌

實體癌第四期: 多型性膠質母細 胞瘤及續發性腦 癌、上皮性卵巢 癌、胰臟癌、攝 護腺癌、頭頸 癌、肝癌、乳 癌、大腸直腸癌

退化性關節炎及 膝關節軟骨缺損

注意事項: 

1. 病人須通過體檢,如自體幹細胞素質太低落,將無法實施。

2. 從取樣-培養-治療需耗時。

3. 費用約100萬-200萬元之間。

 

* 相關細節查詢 : 衛福部官網

 

BlogImage - 2017-03-17 13:07:28醫學進入自體自癒新領域

001_1生物醫學.jpg

 

自體幹細胞激活素有什麼作用?

 

現在如果有一種營養素, 可以驅動自體骨隨裡的幹細胞大量出來工作, 就好比老車全部換零件,身體越來越年輕,是不是很棒? 這是真的。

 

1. 可以在短短60分鐘內,讓身體產生原來80%以上的幹細胞(L選擇性蛋白(L-slected ligand)釋放幹細胞,專利技術),

2. 並且加速它的流動(專利技術),

3. 組織釋放物質(SDF-1)呼喚幹細胞讓幹細胞可以迅速找到受損組織並附著( 幹細胞表皮接收器CXCR4與 SDF-1結合),就像插頭插到插座,立即進行複製, 變成該組織的細胞,

所以,手受傷不會長出眼睛。

當我們人體每天血液中有越多的幹細胞作用時,全身身體的細胞就會慢慢被修復,回復到更年輕的狀態, 這就是幹細胞激活素的功用。

 

科學實證:  

 

2004119日核發的專利: 增加幹細胞運行的方法

專利號碼: Patent No : US6,814,961B1

發明人: Dr. Gitte S. Jensen  (簡森博士)

Christian Drapeu  (卓浦)

簡述: 服用束絲藻AFA萃取物可在動物身上增進幹細胞的運行或趨附,藉由誘導暫時性的增加該動物訊完系統中幹細胞數量的方式

AFA的水生植物中提取出來的兩種複合物混合而成的。其中一種提取物質含有L-選擇素配體 (L-selectin ligand),它可以促進幹細胞(CD34+ cells)從骨髓中釋放出來;另一種提取物富含多糖分子,它可以促進幹細胞從血液中進入組織。

案例報告:

65歲的男性,童年就有免疫系統不健全的問題,成年後出現發炎症狀包括關節炎,服用1.5g AFA兩個星期之後許多部位開始出現組織修復的現象,包括開刀以及40年前車禍前額細碎的玻璃,規律服用AFA兩個星期之後出現約30個小傷口,每一個傷口都含有一個小玻璃碎片,玻璃碎片排出後, 傷口癒合,沒有出現新的疤痕,聽起來太不可思議, 但這是真的。

200111月將論文送到<醫學臆測期刊 (Medical Pypotheses Journal)

     標題: 骨髓幹細胞治療各種退化性疾病(The Use of in situ Bone Marrow  

     Stem Cells for the treatment of various Degenerative Diseases)

      已經證明服用AFA-一種天然生長的可食用產品有此作用。

增加血液中幹細胞專利.jpg

美國專利局證書字號.jpg
 
醫學期刊的報導
 
按此下載論文

Mobilization of human CD34+ CD133+ and CD34+ CD133(-) stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae--related to modulation of CXCR4 expression by an L-selectin ligand?

Source

Holger NIS, 601 13 Avenue NE, Calgary, Alberta, Canada T2E 1C7. gitte@holgernis.com

Abstract

OBJECTIVE:

 
BOOK01.jpg
The goal of this study was to evaluate effects on human stem cells in vitro and in vivo of an extract from the edible cyanobacterium Aphanizomenon flos-aquae (AFA) enriched for a novel ligand for human CD62L (L-selectin).

EXPERIMENTAL APPROACH:

Ligands for CD62L provide a mechanism for stem cell mobilization in conjunction with down-regulation of the CXCR4 chemokine receptor for stromal derived factor 1. Affinity immunoprecipitation was used to identify a novel ligand for CD62L from a water extract from AFA. The effects of AFA water extract on CD62L binding and CXCR4 expression was tested in vitro using human bone marrow CD34+ cells and the two progenitor cell lines, KG1a and K562. A double-blind randomized crossover study involving 12 healthy subjects evaluated the effects of consumption on stem cell mobilization in vivo.

RESULTS:

An AFA extract rich in the CD62L ligand reduced the fucoidan-mediated externalization of the CXCR4 chemokine receptor on bone marrow CD34+ cells by 30% and the CD62L+ CD34+ cell line KG1A by 50% but did not alter the CXCR4 expression levels on the CD34(-) cell line K562. A transient, 18% increase in numbers of circulating CD34+ stem cells maximized 1 hour after consumption (P<.0003). When 3 noncompliant volunteers were removed from analysis, the increase in CD34+ cells was 25% (P<.0001).

CONCLUSION:

AFA water extract contains a novel ligand for CD62L. It modulates CXCR4 expression on CD34+ bone marrow cells in vitro and triggers the mobilization of CD34+ CD133+ and CD34+ CD133(-) cells in vivo.
 
等高線圖的相對分佈的CD34 + CD133 - CD34 + CD133 +和CD34 - CD133 +細胞立即食用前(T0),並在60分鐘後食用

CD34.png

03.jpg

 

 

 

發炎專利.jpg

 

 

 
 
2. AFA(束絲藻) 提取物具修復心肌細胞功能
按此下載論文

Mobilization of bone marrow stem cells with StemEnhance improves muscle regeneration in cardiotoxin-induced muscle injury.

Source

STEMTech HealthSciences, Inc., San Clemente, CA, USA. cdrapeau@stemtechmail.com

Abstract

Bone marrow-derived stem cells have the ability to migrate to sites of tissue damage and participate in tissue regeneration. The number of circulating stem cells has been shown to be a key parameter in this process. Therefore, stimulating the mobilization of bone marrow stem cells may accelerate tissue regeneration in various animal models of injury. In this study we investigated the effect of the bone marrow stem cells mobilizer StemEnhance (SE), a water-soluble extract of the cyanophyta Aphanizomenon flos-aquae (AFA), on hematopoietic recovery after myeloablation as well as recovery from cardiotoxin-induced injury of the anterior tibialis muscle in mice. Control and SE-treated female mice were irradiated, and then transplanted with GFP(+) bone marrow stem cells and allowed to recover. Immediately after transplant, animals were gavaged daily with 300 mg/kg of SE in PBS or a PBS control. After hematopoietic recovery (23 days), mice were injected with cardiotoxin in the anterior tibialis muscle. Five weeks later, the anterior tibialis muscles were analyzed for incorporation of GFP(+) bone marrow-derived cells using fluorescence imaging. SE significantly enhanced recovery from cardiotoxin-injury. However, StemEnhance did not affect the growth of the animal and did not affect hematopoietic recovery after myeloablation, when compared to control. This study suggests that inducing mobilization of stem cells from the bone marrow is a strategy for muscle regeneration.

 

心臟方面01.jpg肌肉組織修復狀況.png肌肉組織修復狀況

 

 

 

3. 美國專利

WO2008000431 A3
EP2032122 A2
US8337858 B2
EP2046354 B1
WO2010115149 A1
US 8034328 B2

Method for enhancing stem cell trafficking
US 8034328 B2

AFA萃取物能提升血液中幹細胞濃度
Consumption of blue-green algae, or extracts thereof, enhances trafficking or homing of stem cells in animals by inducing a transient increase in the population of stem cells present in the animal's circulatory system. The animal may be healthy or suffering some disease or physiological condition.
增加幹細胞流量專利.jpg
 

增加釋放01.png

增加釋放_CD34骨隨幹細胞密度增加.png

增加釋放_L-SELECTION濃度增加.png

增加釋放_CD34+效果超過140%.png

美國醫學中心使用 STEMENHANCE為處方籤案例

 

01.jpg

 

 

 

02.jpg

 

 

 

其他幹細胞療法對各種疾病(遺傳、非遺傳)的研究

幹細胞治療臨床疾病.jpg

長知識_190605_0002.jpg

 

 

 

 

 

 

STEMCELLENHANCE研發者的說明:(英文發音,可使用youtube齒輪使用自動翻譯成中文)

如果您願意每天省下一杯咖啡錢, 照顧自己的健康銀行,請與我們聯繫

如果您對每天100元照顧您的健康銀行有猶豫,請加入我們萬元創業計畫,讓健康變成您的商機

LINE ID: 0922117649    MOMO財富與健康教練

     image

 

arrow
arrow

    健康與財富教練 發表在 痞客邦 留言(0) 人氣()